神经肌肉无力患者的呼吸管理:美国胸科医师学会临床实践指南与专家小组报告
该指南由美国胸科医师学会专家小组制定,系统综述神经肌肉疾病(NMD)呼吸管理文献,采用GRADE方法评估证据确定性并分级推荐,用改良Delphi技术达成共识。基于128项研究,产生15条分级推荐、1条良好实践声明和1条共识声明。证据主要来自肌萎缩侧索硬化(ALS)的观察性数据,最佳实践证据有限。专家组认为每6个月肺功能检查可能有益,临床指征明确时可启动无创通气(NIV);NMD相关慢性呼吸衰竭和睡眠呼吸障碍患者可能受益于个体化NIV设置;资源允许时多导睡眠监测或夜间血氧监测可帮助指导NIV启动。指南还涵盖口含式通气、向家庭机械通气过渡、唾液分泌管理和气道廓清治疗。
要点
- 基于128项研究,专家组制定15条分级推荐、1条良好实践声明和1条共识声明。
- 每6个月肺功能检查可能有益,临床指征明确时可用于启动无创通气(NIV)。
- NMD相关慢性呼吸衰竭和睡眠呼吸障碍患者可能受益于个体化NIV设置。
- 资源允许时,多导睡眠监测或夜间血氧监测可帮助指导NIV启动。
- NMD病理特征多样、肺功能下降速度不同,临床医生应在床旁评估基础上与患者及家属共同决策。
适用人群与场景
- 神经肌肉疾病(NMD)患者,包括肌萎缩侧索硬化(ALS)等肺功能下降速度各异的疾病群体。
- 涉及慢性呼吸衰竭和睡眠呼吸障碍相关的NMD患者。
处置流程与药物剂量
- 每6个月进行肺功能检查可能有益,临床指征明确时可据此启动无创通气(NIV)。
- 对NMD相关慢性呼吸衰竭和睡眠呼吸障碍患者,采用个体化NIV设置可能有益。
- 资源允许时,多导睡眠监测或夜间血氧监测可帮助指导NIV的启动。
- 指南提供了口含式通气、向家庭机械通气过渡、唾液分泌管理和气道廓清治疗的指导。
- 临床医生应在床旁评估基础上,与患者及家属共同决策,尊重患者偏好和治疗目标,考虑生活质量,并合理利用可用资源。
研究设计与关键结果
- 制定机构:美国胸科医师学会(American College of Chest Physicians);方法:系统综述,采用GRADE方法评估证据确定性并制定和分级推荐,用改良Delphi技术达成共识。
- 基于128项研究,专家组产生15条分级推荐、1条良好实践声明和1条共识声明。
- NMD呼吸管理最佳实践证据有限,主要基于肌萎缩侧索硬化(ALS)的观察性数据。
证据类型、等级与局限
- 证据类型:临床实践指南与专家小组报告;采用GRADE方法评估证据确定性并分级推荐,用改良Delphi技术达成共识。
- 局限:NMD呼吸管理最佳实践证据有限,主要基于肌萎缩侧索硬化(ALS)的观察性数据。
对床旁实践的改变
- 对NMD患者,可考虑每6个月进行肺功能检查,临床指征明确时启动无创通气(NIV)。
- 对NMD相关慢性呼吸衰竭和睡眠呼吸障碍患者,可考虑个体化NIV设置。
- 资源允许时,可考虑用多导睡眠监测或夜间血氧监测指导NIV启动。
- 临床医生应将床旁评估加入与患者及家属的共同决策,尊重患者偏好和治疗目标,考虑生活质量,并合理利用可用资源。
指南或共识出处
- 指南名称:神经肌肉无力患者的呼吸管理:美国胸科医师学会临床实践指南与专家小组报告(Respiratory Management of Patients With Neuromuscular Weakness: An American College of Chest Physicians Clinical Practice Guideline and Expert Panel Report);发布机构:美国胸科医师学会(American College of Chest Physicians)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Respiratory failure is a significant concern in neuromuscular diseases (NMDs). This CHEST guideline examines the literature on the respiratory management of patients with NMD to provide evidence-based recommendations.
STUDY DESIGN AND METHODS: An expert panel conducted a systematic review addressing the respiratory management of NMD and applied the Grading of Recommendations, Assessment, Development, and Evaluations approach for assessing the certainty of the evidence and formulating and grading recommendations. A modified Delphi technique was used to reach a consensus on the recommendations.
RESULTS: Based on 128 studies, the panel generated 15 graded recommendations, one good practice statement, and one consensus-based statement.
INTERPRETATION: Evidence of best practices for respiratory management in NMD is limited and is based primarily on observational data in amyotrophic lateral sclerosis. The panel found that pulmonary function testing every 6 months may be beneficial and may be used to initiate noninvasive ventilation (NIV) when clinically indicated. An individualized approach to NIV settings may benefit patients with chronic respiratory failure and sleep-disordered breathing related to NMD. When resources allow, polysomnography or overnight oximetry can help to guide the initiation of NIV. The panel provided guidelines for mouthpiece ventilation, transition to home mechanical ventilation, salivary secretion management, and airway clearance therapies. The guideline panel emphasizes that NMD pathologic characteristics represent a diverse group of disorders with differing rates of decline in lung function. The clinician's role is to add evaluation at the bedside to shared decision-making with patients and families, including respect for patient preferences and treatment goals, considerations of quality of life, and appropriate use of available resources in decision-making.
参考来源
- Khan A, Frazer-Green L, Amin R, et al. Respiratory Management of Patients With Neuromuscular Weakness: An American College of Chest Physicians Clinical Practice Guideline and Expert Panel Report. Chest. 2023. PMID: 36921894. doi:10.1016/j.chest.2023.03.011
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。